IntroDuctIon 5-Hydroxymethylcytosine was first observed in mammals in 1972, but it was not given much attention until recently 1 . In 2009, 5-hmC was found to exist in relatively high abundance in Purkinje neurons and embryonic stem cells (ESCs), and was produced specifically through 5-mC oxidation catalyzed by the Tet family of proteins 2, 3 . 5-hmC is thought to be an intermediate in an active demethylation process and may have direct roles in gene expression, as the modified base itself cannot be recognized by most 5-mC-binding proteins [3] [4] [5] [6] [7] . With the development and application of more sensitive detection technologies, 5-hmC has been found to be present at different levels in the genomes of various cell types or tissues [8] [9] [10] [11] . Genome-wide profiling of 5-hmC further indicates potential regulatory roles of 5-hmC in ESC regulation, myelopoiesis, zygote development and neurodevelopment, thus suggesting that it may serve as an epigenetic mark [12] [13] [14] [15] [16] [17] [18] [19] [20] .
IntroDuctIon
5-Hydroxymethylcytosine was first observed in mammals in 1972, but it was not given much attention until recently 1 . In 2009, 5-hmC was found to exist in relatively high abundance in Purkinje neurons and embryonic stem cells (ESCs), and was produced specifically through 5-mC oxidation catalyzed by the Tet family of proteins 2, 3 . 5-hmC is thought to be an intermediate in an active demethylation process and may have direct roles in gene expression, as the modified base itself cannot be recognized by most 5-mC-binding proteins [3] [4] [5] [6] [7] . With the development and application of more sensitive detection technologies, 5-hmC has been found to be present at different levels in the genomes of various cell types or tissues [8] [9] [10] [11] . Genome-wide profiling of 5-hmC further indicates potential regulatory roles of 5-hmC in ESC regulation, myelopoiesis, zygote development and neurodevelopment, thus suggesting that it may serve as an epigenetic mark [12] [13] [14] [15] [16] [17] [18] [19] [20] .
After the discovery of 5-hmC, several groups independently reported further oxidization of 5-hmC to 5-formylcytosine (5-fC) and 5-caC catalyzed by Tet proteins [21] [22] [23] . Both 5-caC and 5-fC can be recognized and excised by thymine DNA glycosylase (TDG) and then converted back to cytosine through the base excision repair pathway 21, 24, 25 . This newly discovered active demethylation pathway again suggests that 5-hmC is an intermediate of demethylation. 5-hmC accumulates to high abundance in certain brain tissues, implying functional roles other than as an intermediate in demethylation. Determination of the exact location and relative abundance of 5-hmC will be crucial in order to fully unveil the biology associated with this base modification. We describe here a detailed protocol for the TAB-seq method that we recently published for single-base resolution sequencing of 5-hmC 26 .
Development of the protocol
Traditional bisulfite sequencing, which has been widely used to detect 5-mC at single-base resolution, cannot differentiate 5-mC from 5-hmC, as both resist deamination during the treatment of DNA with sodium bisulfite 7, 27 . The protocol described here overcomes this limitation by selectively converting 5-mC to 5-caC in two steps ( Fig. 1) : protection of 5-hmC through glucosylation and mTet1-mediated oxidation of 5-mC to 5-caC. After subsequent bisulfite conversion, the protected β-glucosyl-5-hydroxymethylcytosine (5-gmC; from 5-hmC) is sequenced as C, whereas 5-caC and C read as T, enabling single-base resolution sequencing of 5-hmC 26 .
In the first step, β-GT, a T4 bacteriophage protein, is used to transfer a glucose to the hydroxyl group of 5-hmC and generate 5-gmC 28, 29 . This β-GT-catalyzed glucosylation is highly selective and efficient with either natural or chemically modified uridine diphosphate (UDP)-glucose 11, 30 . Several groups, including ours, have used this selective glucosylation reaction of 5-hmC for the enrichment of 5-hmC-containing genomic DNA fragments 11, [31] [32] [33] .
5-Methylcytosine can be converted to 5-caC by Tet proteins, which is eventually read as T in bisulfite sequencing. 5-fC, which can be partially converted to T under standard bisulfite treatment, can also be oxidized by Tet proteins to 5-caC 34 . Thus, only protected 5-gmC will read as C in TAB-seq. Most reagents in the protocol are readily available. Active mTet1 is now commercially available (Wisegen) and expression as well as purification procedures for wild-type β-GT and the active domain of mTet1 can be followed as reported 11, 13, 26 . We also provide a detailed protocol for producing and purifying a recombinant mTet1 protein (Box 1).
Thus, sensitivity and specificity of 5-hmC detection by TAB-seq depends on sequencing depth. A cytosine base with less-abundant 5-hmC modification (i.e., < 5%) will require more sequencing depth than a base with a higher level of 5-hmC. With RRBS or locus-specific sequencing, a better sensitivity of 5-hmC detection may be achieved owing to higher sequencing depth at selected bases.
Comparison with other methods Affinity-based methods. The affinity-based methods have been widely used to enrich the 5-hmC-containing fragments and profile 5-hmC distribution in the genome. There are two main strategies that were developed previously. One is antibody based, wherein antibodies against 5-hmC 12,36-38 or cytosine 5-methylenesulphonate, the product of 5-hmC after bisulfite treatment 31 , were used. The other is β-GT based and involves one of the following three approaches to achieve selective modification of 5-hmC for affinity purification: (i) an azide-modifed glucose is transferred onto 5-hmC, followed by selective chemical labeling to attach a biotin tag 11 ; (ii) a natural glucose is transferred, followed by periodate oxidation and biotinylation 31 ; or (iii) a protein (JBP1) that specifically recognizes and binds to 5-gmC is used to enrich glucosylated 5-hmC 32, 33 . However, affinity-based methods can neither detect 5-hmC at single-base resolution nor quantify its abundance at the modification site. In the antibody-based approach, recovery of hydroxymethylated fragments can be affected by the density of 5-hmC, especially in 5-hmC immunoprecipitation (hMeDIP), which uses antibodies that recognize 5-hmC 31 . The regions with high 5-hmC density may be overrepresented, whereas the regions with low 5-hmC density may be underrepresented.
Single-molecule real-time sequencing. Single-molecule real-time sequencing can identify modified bases on the basis of the different polymerase passing rates at and around the base. Although this technology is capable of detecting 5-mC and 5-hmC modifications directly, its application is limited by low sensitivity and low throughput 39 . In early 2012, we modified our previous 5-hmC labeling method and combined it with single-molecule real-time (SMRT) DNA sequencing 40 . With larger kinetic signature, increased 5-hmC abundance and reduced amount of DNA to sequence, SMRT sequencing can be applied to detect 5-hmC in genomic DNA at single-base resolution. However, the quantitative information about 5-hmC at each modification site is lost during enrichment. The throughput of the method needs to be improved for the sequencing of large genomes.
Box 1 | Expression and purification of recombinant mTet1
• tIMInG 9-10 d 1. Generate recombinant bacmid and produce recombinant baculovirus P1, P2 and P3 with pFastBac dual-mTet1 using the Bac-to-Bac baculovirus expression system (Invitrogen) according to the manufacturer's instructions. 2. Infect High Five cells by adding 1 ml of P3 baculovirus stock to each culture dish (150 mm × 2.5 mm) with 20 ml of fresh medium for Tet1 expression and incubating at 27 °C for 48 h. 3. Collect cells from 20 dishes by centrifuging at 3,800g for 10 min at 4°C. Wash the cells with mTet1 cell lysis buffer and resuspend the cells in 30 ml of mTet1 cell lysis buffer.  crItIcal step During the purification, all the steps should be performed on ice or at 4 °C.  pause poInt Cells can be frozen in liquid nitrogen and stored at − 80 °C for at least 3 months. 4. Break the cells by flowing them through the homogenizer twice. 5. Centrifuge the cell lysate at 30,000g for 40 min at 4 °C. 6. Add 3 ml of Anti-flag M2 affinity gel to the Econo-Column and wash it with at least 60 ml of mTet1 cell lysis buffer using gravity. 7. Load the clarified cell lysate to the equilibrated Anti-flag M2 affinity gel and then resuspend. Incubate at 4 °C for 10 min. 8. Let the cell lysate flow through using gravity at the rate of 1 drop per s. 9. Load the flow-through back to the gel and repeat steps 7 and 8 once. 10. Wash the gel with at least 200 ml of mTet1 cell lysis buffer using gravity. 11. Add 1 mM TCEP, 1 mM PMSF, 1 µg ml − 1 leupeptin and 1 µg ml − 1 pepstatin to the 3× Flag peptide (0.2 mg ml − 1 ). 12. Resuspend the gel with 3 ml of 3× Flag peptide and elute the protein with a flow rate of 1 drop per s after incubating for 10 min. 13. Repeat step 12 twice more. 14. Concentrate the eluate to 2 ml and then apply it to the 120 ml Superdex-200 column equilibrated with mTet1 gel filtration running buffer. 15. Collect the peak fraction and concentrate mTet1 with an Amicon Ultra-4 filter (MWCO 30,000 Da) to around 3 mg ml − 1 . 16. Add glycerol to purified mTet1 to 30% (vol/vol) and aliquot. Freeze the protein in liquid nitrogen and store it at − 80 °C.  crItIcal step Storage of mTet1 above − 80 °C may lead to decreased 5-mC oxidation efficiency. Oxidative bisulfite sequencing. Oxidative bisulfite sequencing (oxBS-seq), which can discriminate 5-mC from 5-hmC, was recently reported 34 . In this modified bisulfite-sequencing method, KRuO 4 selectively oxidizes 5-hmC to 5-fC at high efficiency, followed by conversion to T in subsequent bisulfite treatment and PCR amplification. A comparison of the results of oxBS-seq with those of standard bisulfite sequencing allows for the quantitative sequencing of both 5-mC and 5-hmC at single-base resolution. Application of oxBS-seq requires multiple rounds of bisulfite treatment to fully deaminate 5-fC, and chemical oxidation may cause extensive oxidative DNA damage. Compared with oxBS-seq, TAB-seq gives direct reads of 5-hmC, and the treatment procedure incurs less DNA damage 34 . However, TAB-seq requires highly active Tet protein for efficient conversion of 5-mC to 5-caC.
Experimental design
Purification of the active domain of mTet1. As incomplete oxidation of 5-mC will result in false-positive 5-hmC signals, the availability of highly active mTet1 protein is crucial to TAB-seq. The expression and purification procedures of recombinant mTet1 are described in Box 1. To ensure high activity of the recombinant mTet1, all steps must be performed at 4 °C or on ice during purification. Aliquots of mTet1 proteins are stored at − 80 °C before use. Improper storage or multiple freeze-thaw cycles (more than twice) may result in decreased oxidation activity. The protocol to test the activity of purified mTet1 is described in Box 2; it is strongly recommended to carry out the activity test on each batch of newly purified recombinant mTet1 before applying it to TAB-seq.
Spike-in control. For both locus-specific and whole-genome sequencing, two key parameters exist for an accurate estimation of 5-hmC abundance besides the conversion rate of unmodified cytosine to uracil: the oxidation efficiency of 5-mC to 5-caC and the protection efficiency of 5-hmC. Although nonprotected 5-hmC can result in an underestimation of 5-hmC abundance, nonconversion of unmodified C and 5-mC will result in falsepositive 5-hmC signals, and should therefore be determined in each experiment. With sufficiently high C and mC conversion rates and 5-hmC protection rates, the abundance of 5-hmC can be quantified from the frequency with which C is read compared with T at a given genomic position in any sequencing experiment. To assess the conversion rates in genomic DNA, controls containing 5-mC and 5-hmC need to be spiked in before treatment. Such controls should be of sufficient complexity and contain modified cytosines in various sequence contexts (i.e., multiple CpGs throughout). For genome-wide sequencing, spike-in DNA should span at least 1 kb of the sequence, such that subsequent random fragmentation by sonication and sequencing can distinguish PCR duplicates. Furthermore, after bisulfite conversion, spike-in DNA should not align to a bisulfite-converted target genome. In practice, we find that DNA from the lambda phage and the pUC19 plasmid work well as spike-ins for mouse and human samples.
For the 5-mC control, DNA can either be selectively methylated at CpG sites using CpG methyltransferase or amplified with 5-mdCTP. However, the CpG-methylated control is recommended, as the frequent neighboring 5-mC generated by PCR may lead to the underestimation of the oxidation efficiency.
For the 5-hmC control, there is no enzyme that can selectively generate 100% 5-hmC from C or 5-mC; therefore, besides synthesizing long oligonucleotides containing 5-hmC at required positions, the easiest and most cost-effective way to generate DNA longer than 1 kb with multiple 5-hmC sites may be through PCR amplification with 5-hydroxymethyl dCTP (5-hmdCTP). With this method, each C position is supposed to be 100% 5-hmC. However, we have found that many commercial 5-hmdCTPs contain contaminant dCTP, which will result in the underestimation of protection efficiency because unmodified cytosine will display as 'T' in TAB-seq (Fig. 2) . Purifying the commercial 5-hmdCTP with HPLC offers one solution to this problem and takes about 2 d (Box 3) . However, it should be noted that it may be difficult to amplify fragments larger than 2 kb with purified 5-hmdCTP. Alternatively, if experiments are run alongside conventional bisulfite treatments, dCTP contamination can be adjusted for by direct measurement of bisulfite-converted cytosine in the 5-hmC spike-in control. Typically, > 90% protection efficiency can be achieved for 5-hmC protection after taking contamination into account.
In this protocol, we use methylated λ-DNA as C and 5-mC control in both genome-wide and locus-specific sequencing. For the 5-hmC control, a PCR product of 1.64 kb from a pUC19 vector (5-hmC control 1; generated with 5-hmC_F_1 and 5-hmC_R_1 primers) is used for the estimation of 5-hmC protection efficiency only in genome-wide sequencing. The 290-bp control (5-hmC control 2; generated with 5-hmC_F_2 and 5-hmC_R_2 primers), which is relatively easier to amplify and clone after bisulfite treatment, is used for the verification of 5-hmC protection efficiency after β-GT and mTet1 treatment with TOPO cloning. In both 5-hmC spike-in controls, all Cs are 5-hmC except for those in the primer sequence .
Verification of 5-mC conversion and 5-hmC protection on spikein controls with TOPO cloning is strongly recommended after β-GT and mTet1 treatment but the procedure before proceeding with large-scale sequencing. However, it may be simplified if no quantitative conversion or protection rate is required for locusspecific sequencing.
Data analysis. Data analysis for TAB-seq and traditional bisulfite sequencing are nearly identical. At each genomic locus, the estimated abundance of 5-hmC (A 5-hmC ) is measured as the number of cytosine base calls divided by the total (C + T) sequencing depth at the locus. For genome-wide analysis, only good-quality base calls (Phred score of 20 or greater) are considered. To correct for the 5-hmC protection rate (r 5-hmC ) not being 100% efficient, the absolute abundance of 5-hmC is calculated as E 5hmC = A 5hmC / r 5hmC .
Box 3 | Purification of commercial 5-hmdCTP with HPLC • tIMInG 2 d
The resolution of TAB-seq to detect 5-hmC is crucially dependent on sequencing depth. For example, the median abundance of 5-hmC at 5-hmC sites in H1 ESCs is just under 20%, and detecting base-resolution 5-hmC at this level requires sequencing at a depth of ~25 times per cytosine, or ~50 times the haploid genome size. For cells with higher levels of 5-hmC, less sequencing is required: we estimate that a depth of ~15 times per cytosine is sufficient to detect base-resolution 5-hmC with an abundance of 30%.
If base-resolution precision is not necessary, much less sequencing is required. We recommend sequencing reads with a length of at least 100 bp. Please see genome-wide bisulfite sequencing methods for additional details 26, 41 .
The entire workflow for the method is shown in Figure 3 . The details of all oligonucleotides used in this protocol are listed in Table 1 . Supplementary Note 1 shows the sequence of the 5-hmC spike-in controls. 2| Mix well and allow the reaction to proceed at 37 °C for 2 h, followed by heating at 65 °C for 20 min to stop the reaction.  crItIcal step Use fresh S-adenosylmethionine.
3|
Clean up the DNA with the QIAEX II gel extraction kit and elute methylated DNA in 20 µl of Milli-Q water by following the manufacturer's instructions. 
9|
Sonicate the genomic DNA in 120 µl of EB buffer to the desired size range. We typically sonicate for 55 s using a Covaris system, with a 10% duty cycle, intensity set at 4 and cycle per burst set at 200 in order to achieve the size range of 200-500 bp.  crItIcal step Because of platform and machine variability, the precise sonication parameters should be tested before sample preparation. Increasing or decreasing the length of sonication will decrease and increase, respectively, the size distribution of fragments. The desired size range depends on the downstream sequencing parameters.  crItIcal step Always analyze DNA fragmentation by running an aliquot on an agarose gel before proceeding to Step 10.
10| Add 2.5 ng (0.25%) of 5-hmC control 2 (~300 bp from tube 2 at Step 7, amplified with 5-hmC_F_2 and 5-hmC R_2 primers) after sonication to each 1 µg of genomic DNA for both genome-wide sequencing and locus-specific sequencing.
11| Purify the sonicated genomic DNA with the Qiagen MinElute PCR purification kit according to the manufacturer's instructions; elute the DNA in 10 µl of Milli-Q water.  crItIcal step Fragments with a size of < 70 bp will be eliminated after purification.  pause poInt The sonicated genomic DNA can be stored at − 20 °C for several months.  crItIcal step For genome-wide sequencing, perform at least three reactions in parallel (1.5 µg of glucosylated DNA input in total) to obtain enough DNA for library generation. If more than 2% of the whole genome is 5-mC in the genomic DNA of interest, increase the concentration of mTet1 accordingly.
16| Mix well and allow the reaction to proceed at 37 °C for 80 min.
17| Add 1 µl of proteinase K (20 mg ml − 1 ) to the reaction mixture and incubate at 50 °C for 1 h. Step 22 by using the Qiagen PCR purification kit and then apply it to Sanger sequencing (Step 25).
24|
Calculate the conversion rate of unmodified C, the conversion rate of 5-mC and the 5-hmC protection rate. The conversion rate of unmodified C from non-CpG cytosines in 5-mC/C spike-in control is usually over 99%. The ideal conversion rate of 5-mC is > 96% and the protection efficiency of 5-hmC is > 80% in the 5hmC spike-in control. The conversion rate of unmodified C = number of 'T' reads at non-CpG cytosines/(number of non-CpG cytosines × number of clones sequenced). The conversion rate of 5-mC = number of 'T' reads at CpG cytosines/(number of non-CpG cytosines × number of clones sequenced). The protection efficiency of 5-hmC = number of 'C' reads at cytosines/(number of cytosines × number of clones sequenced).  crItIcal step Do not take the cytosines of the primer sequence into consideration when doing the calculation. ? trouBlesHootInG sequencing of genomic Dna 25| Analyze the treated genomic DNA by locus-specific sequencing (option A) or whole-genome sequencing (option B).
(a) locus-specific sequencing • tIMInG 12 h (i) Apply ~200 ng of treated genomic DNA (from Step 18) to the Qiagen Epitect bisulfite kit by following the manufacturer's instructions. Other bisulfite conversion kits can also be used.  pause poInt The bisulfite-treated DNA can be stored at − 20 °C for several weeks. (ii) Use the table below as a guide to prepare 50-µl PCRs with primers designed to detect 5-hmC at the loci of interest. ? trouBlesHootInG Troubleshooting advice can be found in table 2.
